These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9596890)

  • 21. Pharmacokinetic and pharmacodynamic advantages of pirarubicin over adriamycin after intraarterial hepatic administration in the rabbit VX2 tumor model.
    Munck JN; Riggi M; Rougier P; Chabot GG; Ramirez LH; Zhao Z; Bognel C; Ardouin P; Herait P; Gouyette A
    Cancer Res; 1993 Apr; 53(7):1550-4. PubMed ID: 8453622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnetic resonance imaging of temperature-sensitive liposome release: drug dose painting and antitumor effects.
    Ponce AM; Viglianti BL; Yu D; Yarmolenko PS; Michelich CR; Woo J; Bally MB; Dewhirst MW
    J Natl Cancer Inst; 2007 Jan; 99(1):53-63. PubMed ID: 17202113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic and tissue distribution changes of adriamycin and adriamycinol after intravenous administration of adriamycin to alloxan-induced diabetes mellitus rats.
    Lee HJ; Paik WH; Lee MG
    Res Commun Mol Pathol Pharmacol; 1995 Aug; 89(2):165-78. PubMed ID: 8556271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Preparation and lymphatic targeting research of targeting antitumor drug: pectin-adriamycin conjugates].
    Cheng M; Xie P; Tang X; Zhang J; Xie Y; Zheng K; He J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Jun; 26(3):569-74. PubMed ID: 19634675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Efficacy of activated charcoal-epirubicin suspension for treatment of breast cancer with axillary metastasis].
    Wu WJ; Zeng J; Pan CE
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1812-4. PubMed ID: 17259127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pegylated liposomes have potential as vehicles for intratumoral and subcutaneous drug delivery.
    Harrington KJ; Rowlinson-Busza G; Syrigos KN; Uster PS; Vile RG; Stewart JS
    Clin Cancer Res; 2000 Jun; 6(6):2528-37. PubMed ID: 10873109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of intermittent and continuous thermochemotherapeutic intra artery infusion on adriamycin concentration in rabbit VX-2 tumor].
    Zhang HX; Liu Y; He XL; Liu YY; Cao W; Wei J; Ni DH; Li WX; Han RY
    Ai Zheng; 2004 Apr; 23(4):372-5. PubMed ID: 15087021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel doxorubicin-glucuronide prodrug DOX-GA3 for tumour-selective chemotherapy: distribution and efficacy in experimental human ovarian cancer.
    Houba PH; Boven E; van der Meulen-Muileman IH; Leenders RG; Scheeren JW; Pinedo HM; Haisma HJ
    Br J Cancer; 2001 Feb; 84(4):550-7. PubMed ID: 11207053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase I and pharmacokinetic study of a stable, polyethylene-glycolated liposomal doxorubicin in patients with solid tumors: the relation between pharmacokinetic property and toxicity.
    Hong RL; Tseng YL
    Cancer; 2001 May; 91(9):1826-33. PubMed ID: 11335910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted adriamycin delivery to MXT-B2 metastatic mammary carcinoma cells by transferrin liposomes: effect of adriamycin ADR-to-lipid ratio.
    Lopez-Barcons LA; Polo D; Llorens A; Reig F; Fabra A
    Oncol Rep; 2005 Nov; 14(5):1337-43. PubMed ID: 16211306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic and tissue distribution changes of adriamycin and adriamycinol after intravenous administration of adriamycin to uranyl nitrate-induced acute renal failure rats.
    Lee HJ; Paik WH; Lee MG
    Res Commun Mol Pathol Pharmacol; 1996 Feb; 91(2):195-204. PubMed ID: 8832911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Basic study on hepatic artery chemoembolization and tumor selective drug targeting by temperature-sensitive liposome with local hyperthermia].
    Ueno M; Zou YY; Yamagishi M; Horikoshi I
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3735-8. PubMed ID: 2596857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Higher plasma but not intracellular concentrations after infusion with liposomal daunorubicin compared with conventional daunorubicin in adult acute myeloid leukemia.
    Löfgren C; Lehmann S; Jönsson-Videsäter K; Möllgård L; Linder O; Tidefelt U; Hassan M; Paul C
    Ther Drug Monit; 2007 Oct; 29(5):626-31. PubMed ID: 17898654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The experiment of pegylated liposomal doxorubicin to therapy tongue cancer and metastases lymph nodes].
    Chen S; Pan J; Liao X
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2001 Sep; 36(5):338-40. PubMed ID: 11769644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional pharmacokinetics of doxorubicin following hepatic arterial and portal venous administration: evaluation with hepatic venous isolation and charcoal hemoperfusion.
    Iwasaki T; Ku Y; Kusunoki N; Tominaga M; Fukumoto T; Muramatsu S; Kuroda Y
    Cancer Res; 1998 Aug; 58(15):3339-43. PubMed ID: 9699664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates.
    Allen TM; Mumbengegwi DR; Charrois GJ
    Clin Cancer Res; 2005 May; 11(9):3567-73. PubMed ID: 15867261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial?
    Hong RL; Huang CJ; Tseng YL; Pang VF; Chen ST; Liu JJ; Chang FH
    Clin Cancer Res; 1999 Nov; 5(11):3645-52. PubMed ID: 10589782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pegylated liposomal doxorubicin in ovarian cancer.
    Green AE; Rose PG
    Int J Nanomedicine; 2006; 1(3):229-39. PubMed ID: 17717964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Preparation of doxorubicin-loaded chitosan polymeric micelle and study on its tissue biodistribution in mice].
    Xu XY; Zhou JP; Li L; Zhang Y; Huo MR; Wang X; Lü L
    Yao Xue Xue Bao; 2008 Jul; 43(7):743-8. PubMed ID: 18819480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting chemotherapy using antibody-combined liposome against human pancreatic cancer cell-line.
    Akaishi S; Kobari M; Takeda K; Matsuno S
    Tohoku J Exp Med; 1995 Jan; 175(1):29-42. PubMed ID: 7610458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.